Cereno Scientific AB (publ) (CRNO.B)
Free
No email, no account, no signup.
Pulling latest news for Cereno Scientific AB (publ)…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
Nasdaq First North
Type
Biotech
Sector
Biotech, cardiovascular and pulmonary diseases
Market Cap
$190M
We're already tracking Cereno Scientific AB (publ) — here are the latest events we've registered
Recent News
- On March 31, 2026, Cereno Scientific reported favorable 12-month safety and tolerability data for its lead candidate CS1 from an Expanded Access Program in pulmonary arterial hypertension. The company is preparing to initiate a global Phase IIb trial for CS1, with first patient enrollment anticipated in June 2026. In March 2026, the company also received approval to start a Phase I pharmacokinetic study for its drug candidate CS014.
Want to know how this news affects Cereno Scientific AB (publ)? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Cereno Scientific AB (publ) will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.